AKUMS Share Price Performance
₹553.80
-10.35 (-1.83%)
14.4% undervalued intrinsic discount
₹646.67
Fair Value
Price ₹553.80
AnalystConsensusTarget ₹646.67
Fair Value₹646.67
Share Pricen/a
Analysis Article • May 22
Akums Drugs and Pharmaceuticals Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 17 Fair Values set on narratives written by author
AKUMS Community Narratives
AN
Fair Value
·Fair Value ₹646.67 14.4% undervalued intrinsic discount
Global Expansion In Europe, Brazil And India Will Unlock Opportunities
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
Global Expansion In Europe, Brazil And India Will Unlock Opportunities
Key Takeaways Expansion into regulated markets and diversified offerings position Akums for sustained top-line growth and improved earnings quality. Strategic investments and a strong balance sheet enable capacity growth, acquisitions, and leverage rising demand across key pharmaceutical segments.Read more
AN
₹646.67
14.4% undervalued intrinsic discount
Fair Value
Revenue
12.36% p.a.
Profit Margin
9.26%
Future PE
27.14x
Price in 2029
₹951.97
Trending Discussion
Recently Updated Narratives
AN
AKUMS: Zambia Manufacturing Buildout Will Support Future Earnings Expansion
Fair Value: ₹646.67 14.4% undervalued intrinsic discount
7 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Akums Drugs and Pharmaceuticals Limited Key Details
About AKUMS
- Founded
- 2004
- Employees
- 7536
- CEO
- WebsiteView website
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, herbals, toiletries, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, capsules, injectables, opthalmics, and soft gelatin capsules for therapeutic areas, such as gynaecology, cardiology, orthopaedics, pediatrics, and dermatology, as well as anti-infectives, pain management and gastroenterology. In addition, the company operates as pharmaceutical contract development and manufacturing company. The company was incorporated in 2004 and is based in Delhi, India.
